| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2023 | 4.21% | BMO Capital | $25 → $24 | Maintains | Market Perform |
| 11/06/2023 | 12.9% | Piper Sandler | $30 → $26 | Maintains | Neutral |
| 11/06/2023 | 17.24% | Barclays | $28 → $27 | Maintains | Overweight |
| 11/06/2023 | 21.58% | Raymond James | $29 → $28 | Downgrades | Strong Buy → Outperform |
| 11/02/2023 | 12.9% | UBS | $28 → $26 | Maintains | Neutral |
| 10/25/2023 | 12.9% | Citigroup | $29 → $26 | Maintains | Neutral |
| 10/23/2023 | 21.58% | Barclays | $31 → $28 | Maintains | Overweight |
| 10/19/2023 | 8.55% | Deutsche Bank | → $25 | Initiates Coverage On | → Hold |
| 10/18/2023 | 25.92% | Raymond James | $33 → $29 | Maintains | Strong Buy |
| 10/11/2023 | 12.9% | Morgan Stanley | $27 → $26 | Maintains | Equal-Weight |
| 08/02/2023 | 17.24% | Morgan Stanley | $27 → $27 | Reiterates | Equal-Weight → Equal-Weight |
| 08/02/2023 | 17.24% | BMO Capital | $28 → $27 | Maintains | Market Perform |
| 08/02/2023 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 07/24/2023 | 30.26% | Citigroup | $28 → $30 | Maintains | Neutral |
| 07/18/2023 | 21.58% | Piper Sandler | → $28 | Initiates Coverage On | → Neutral |
| 07/17/2023 | 17.24% | Morgan Stanley | $27 → $27 | Reiterates | Equal-Weight → Equal-Weight |
| 05/01/2023 | 38.95% | Credit Suisse | $31 → $32 | Maintains | Outperform |
| 02/21/2023 | 17.24% | Morgan Stanley | $25 → $27 | Maintains | Equal-Weight |
| 02/17/2023 | 25.92% | Citigroup | $25 → $29 | Maintains | Neutral |
| 02/17/2023 | 34.61% | Barclays | $24 → $31 | Maintains | Overweight |
| 02/17/2023 | 34.61% | Credit Suisse | $27 → $31 | Maintains | Outperform |
| 02/17/2023 | 43.29% | Raymond James | $30 → $33 | Maintains | Strong Buy |
| 01/25/2023 | 17.24% | B of A Securities | → $27 | Initiates Coverage On | → Neutral |
| 01/25/2023 | 12.9% | BMO Capital | $29 → $26 | Downgrades | Outperform → Market Perform |
| 01/24/2023 | 30.26% | Raymond James | $27.5 → $30 | Maintains | Strong Buy |
| 01/18/2023 | 8.55% | Morgan Stanley | $23 → $25 | Maintains | Equal-Weight |
| 01/05/2023 | 4.21% | Barclays | $28 → $24 | Maintains | Overweight |
| 10/31/2022 | -0.13% | Morgan Stanley | $21 → $23 | Maintains | Equal-Weight |
| 10/31/2022 | 21.58% | Barclays | $26 → $28 | Maintains | Overweight |
| 10/21/2022 | -0.13% | UBS | → $23 | Initiates Coverage On | → Neutral |
| 10/11/2022 | -8.81% | Morgan Stanley | $22 → $21 | Maintains | Equal-Weight |
| 08/01/2022 | -4.47% | Morgan Stanley | $21 → $22 | Maintains | Equal-Weight |
| 07/19/2022 | 19.41% | Raymond James | $30 → $27.5 | Maintains | Strong Buy |
| 07/18/2022 | -8.81% | Morgan Stanley | $26 → $21 | Maintains | Equal-Weight |
| 06/16/2022 | -17.5% | Citigroup | $24 → $19 | Maintains | Neutral |
| 06/09/2022 | 12.9% | Barclays | $29 → $26 | Maintains | Overweight |
| 06/03/2022 | 30.26% | MKM Partners | $32 → $30 | Maintains | Buy |
| 05/02/2022 | 12.9% | Morgan Stanley | $25 → $26 | Maintains | Equal-Weight |
| 04/14/2022 | 8.55% | Morgan Stanley | $27 → $25 | Maintains | Equal-Weight |
| 04/12/2022 | 4.21% | Citigroup | → $24 | Initiates Coverage On | → Neutral |
| 02/22/2022 | 17.24% | Morgan Stanley | $25 → $27 | Maintains | Equal-Weight |
| 02/22/2022 | 30.26% | Deutsche Bank | $34 → $30 | Maintains | Buy |
| 02/22/2022 | 43.29% | BMO Capital | $30 → $33 | Maintains | Outperform |
| 02/22/2022 | 30.26% | Raymond James | $28 → $30 | Maintains | Strong Buy |
| 01/26/2022 | 21.58% | Raymond James | $30 → $28 | Maintains | Strong Buy |
| 01/14/2022 | 8.55% | Morgan Stanley | $28 → $25 | Maintains | Equal-Weight |
| 12/15/2021 | 12.9% | Barclays | $30 → $26 | Maintains | Overweight |
| 11/03/2021 | 21.58% | Morgan Stanley | $31 → $28 | Maintains | Equal-Weight |
| 11/03/2021 | 30.26% | Barclays | $37 → $30 | Maintains | Overweight |
| 11/03/2021 | 30.26% | Raymond James | $37.5 → $30 | Maintains | Strong Buy |
| 10/18/2021 | 60.66% | Barclays | $40 → $37 | Maintains | Overweight |
| 10/13/2021 | 34.61% | Morgan Stanley | $32 → $31 | Maintains | Equal-Weight |
| 08/03/2021 | 21.58% | Goldman Sachs | $26 → $28 | Upgrades | Sell → Neutral |
| 08/03/2021 | 43.29% | Credit Suisse | $32 → $33 | Upgrades | Neutral → Outperform |
| 08/02/2021 | 47.63% | Deutsche Bank | → $34 | Upgrades | Hold → Buy |
| 05/21/2021 | — | Gordon Haskett | Upgrades | Hold → Buy | |
| 04/30/2021 | 62.83% | Raymond James | $32.5 → $37.5 | Maintains | Strong Buy |
| 04/30/2021 | 38.95% | Morgan Stanley | $28 → $32 | Maintains | Equal-Weight |
| 03/26/2021 | 21.58% | Morgan Stanley | $25 → $28 | Maintains | Equal-Weight |
| 03/22/2021 | 41.12% | Raymond James | $29 → $32.5 | Maintains | Strong Buy |
| 03/09/2021 | 21.58% | Deutsche Bank | → $28 | Downgrades | Buy → Hold |
| 02/22/2021 | 8.55% | Morgan Stanley | $21 → $25 | Maintains | Equal-Weight |
| 02/19/2021 | 12.9% | Wells Fargo | $25 → $26 | Maintains | Equal-Weight |
| 02/19/2021 | 8.55% | Morgan Stanley | $21 → $25 | Maintains | Equal-Weight |
| 02/19/2021 | 12.9% | Credit Suisse | $21 → $26 | Maintains | Neutral |
| 02/19/2021 | 25.92% | Raymond James | $27.5 → $29 | Maintains | Strong Buy |
| 02/19/2021 | -4.47% | Goldman Sachs | $20 → $22 | Maintains | Sell |
| 01/26/2021 | 19.41% | Raymond James | $24 → $27.5 | Maintains | Strong Buy |
| 01/22/2021 | 12.9% | Deutsche Bank | $22 → $26 | Maintains | Buy |
| 01/19/2021 | -13.16% | Goldman Sachs | → $20 | Initiates Coverage On | → Sell |
| 01/19/2021 | -8.81% | Morgan Stanley | $18 → $21 | Maintains | Equal-Weight |
| 12/02/2020 | -4.47% | Raymond James | $21 → $22 | Maintains | Strong Buy |
| 11/16/2020 | -4.47% | BMO Capital | → $22 | Upgrades | Market Perform → Outperform |
| 10/26/2020 | -26.18% | Credit Suisse | $12 → $17 | Maintains | Neutral |
| 10/26/2020 | -21.84% | Morgan Stanley | $17 → $18 | Maintains | Equal-Weight |
| 10/14/2020 | -26.18% | Morgan Stanley | $12 → $17 | Maintains | Equal-Weight |
| 10/12/2020 | -8.81% | Raymond James | $20 → $21 | Maintains | Strong Buy |
| 09/14/2020 | -13.16% | Raymond James | $18 → $20 | Maintains | Strong Buy |
| 09/01/2020 | -21.84% | Raymond James | → $18 | Upgrades | Outperform → Strong Buy |
| 09/01/2020 | -13.16% | Deutsche Bank | → $20 | Upgrades | Hold → Buy |
| 07/27/2020 | -30.53% | JP Morgan | $15 → $16 | Upgrades | Neutral → Overweight |
| 07/27/2020 | -47.89% | Morgan Stanley | $10 → $12 | Maintains | Equal-Weight |
| 07/23/2020 | -43.55% | B of A Securities | → $13 | Upgrades | Underperform → Neutral |
| 07/09/2020 | -47.89% | Credit Suisse | → $12 | Initiates Coverage On | → Neutral |
| 07/01/2020 | -47.89% | Gordon Haskett | $14 → $12 | Downgrades | Buy → Hold |
| 05/29/2020 | -30.53% | Jefferies | $12 → $16 | Upgrades | Hold → Buy |
| 05/11/2020 | -56.58% | BMO Capital | $9 → $10 | Maintains | Market Perform |
| 05/11/2020 | -43.55% | Barclays | $29 → $13 | Maintains | Overweight |
| 05/11/2020 | -34.87% | Guggenheim | $11 → $15 | Maintains | Buy |
| 05/11/2020 | -47.89% | Wells Fargo | $11 → $12 | Maintains | Equal-Weight |
| 05/11/2020 | -56.58% | Morgan Stanley | $7 → $10 | Maintains | Equal-Weight |
| 05/11/2020 | -34.87% | Deutsche Bank | $14 → $15 | Maintains | Hold |
| 05/11/2020 | -39.21% | Raymond James | $15 → $14 | Maintains | Outperform |
| 05/05/2020 | -52.24% | Wells Fargo | $23 → $11 | Maintains | Equal-Weight |
| 05/04/2020 | -43.55% | MKM Partners | $11 → $13 | Maintains | Buy |
| 04/22/2020 | -56.58% | Jefferies | $6 → $10 | Maintains | Hold |
| 04/20/2020 | -52.24% | MKM Partners | $9 → $11 | Maintains | Buy |
| 04/17/2020 | -39.21% | Deutsche Bank | $23 → $14 | Maintains | Hold |
| 04/02/2020 | -47.89% | Raymond James | $26 → $12 | Maintains | Outperform |
| 12/19/2019 | -0.13% | Morgan Stanley | $21 → $23 | Maintains | Equal-Weight |
| 12/12/2019 | 8.55% | Goldman Sachs | → $25 | Initiates Coverage On | → Buy |
| 11/07/2019 | 12.9% | Raymond James | $23 → $26 | Maintains | Outperform |
| 11/07/2019 | -13.16% | BMO Capital | $19 → $20 | Maintains | Market Perform |
| 11/07/2019 | 12.9% | MKM Partners | $20 → $26 | Maintains | Buy |
| 11/07/2019 | 8.55% | JP Morgan | $21 → $25 | Downgrades | Overweight → Neutral |
| 10/18/2019 | -17.5% | Morgan Stanley | $20 → $19 | Maintains | Equal-Weight |
| 10/18/2019 | -4.47% | Barclays | $24 → $22 | Maintains | Overweight |
| 10/15/2019 | -8.81% | Deutsche Bank | $23 → $21 | Downgrades | Buy → Hold |
| 09/05/2019 | -17.5% | BMO Capital | $17 → $19 | Upgrades | Underperform → Market Perform |
| 08/13/2019 | -13.16% | MKM Partners | → $20 | Initiates Coverage On | → Buy |
| 07/23/2019 | -4.47% | Loop Capital | → $22 | Initiates Coverage On | → Buy |
| 06/28/2019 | -4.47% | JP Morgan | $23 → $22 | Maintains | Overweight |
| 06/28/2019 | 4.21% | Deutsche Bank | → $24 | Initiates Coverage On | → Buy |
| 05/24/2019 | — | Guggenheim | Upgrades | Neutral → Buy | |
| 05/23/2019 | -21.84% | BMO Capital | $23 → $18 | Downgrades | Market Perform → Underperform |
| 02/15/2019 | — | William Blair | Upgrades | Market Perform → Outperform | |
| 02/08/2019 | — | B of A Securities | Downgrades | Underperform → Neutral | |
| 01/08/2019 | -0.13% | JP Morgan | → $23 | Upgrades | Neutral → Overweight |
| 12/19/2018 | — | Morgan Stanley | Upgrades | Underweight → Equal-Weight | |
| 11/29/2018 | 8.55% | Barclays | $27 → $25 | Maintains | Overweight |
What is the target price for Bloomin Brands (BLMN)?
The latest price target for Bloomin Brands (NASDAQ: BLMN) was reported by BMO Capital on November 7, 2023. The analyst firm set a price target for $24.00 expecting BLMN to rise to within 12 months (a possible 4.21% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bloomin Brands (BLMN)?
The latest analyst rating for Bloomin Brands (NASDAQ: BLMN) was provided by BMO Capital, and Bloomin Brands maintained their market perform rating.
When is the next analyst rating going to be posted or updated for Bloomin Brands (BLMN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bloomin Brands, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bloomin Brands was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.
Is the Analyst Rating Bloomin Brands (BLMN) correct?
While ratings are subjective and will change, the latest Bloomin Brands (BLMN) rating was a maintained with a price target of $25.00 to $24.00. The current price Bloomin Brands (BLMN) is trading at is $23.03, which is out of the analyst's predicted range.